19 Nov 2018 | 7:13 AM
 

Ajanta Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 532331 | NSE Symbol: AJANTPHARM
1,119.66
36.35
(3.36 %)
16 Nov 2018 | 04:01 PM
Change company
  • Open (Rs)
    1,098.80
  • Prev. close (Rs.)
    1,083.30
  • High (Rs.)
    1,140.00
  • Low (Rs.)
    1,090.30
  • 52W H (Rs.)
    1,592.00
  • 52W L (Rs.)
    897.60
  • Volume
    58094
  • MCap (Rs in Cr.)
    9,855.50
1124.7
36.50
(3.35 %)
  • Open (Rs)
    1,095.95
  • High (Rs)
    1,143.75
  • Low (Rs)
    1,095.05
  • Prev. close(Rs)
    1,088.20
  • Contracts Tra.
    17,80,500
  • Turnover (Cr.)
    201
  • Open Interest
    7,68,500
  • Open Int. chg
    1,78,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
53.25
Operating Margin (%)
30.97
Gross Profit Margin (%)
28.16
Net Profit Margin (%)
22.04
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

01 Nov 2018 - 11:21:00-Ajanta Pharma Wednesday reported 4.92 per cent dip in consolidated net profit to Rs 125...
31 Jul 2018 - 16:44:00-Ajanta Pharma today reported 11.60 per cent rise in consolidated net profit at Rs 105...
27 Jul 2018 - 14:47:00-Drug firm Ajanta Pharma today said the US health regulator has not made any observations after compl...
03 May 2018 - 14:50:00-The company reported standalone net profit of Rs 78...

Announcements

02-Nov-2018
Ajanta Pharma Lt - Financial Result Updates
01-Nov-2018
Ajanta Pharma Lt - Compliance Under Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations
31-Oct-2018
Ajanta Pharma Lt - Corporate Action-Board approves Dividend
31-Oct-2018
Ajanta Pharma Lt - Dividend
31-Oct-2018
Ajanta Pharma Lt - Announcement under Regulation 30 (LODR)-Investor Presentation

Religare Research

16 Nov 2018 | 07:00 PM
Incorporated in 1962, Tata Global Beverages Ltd is amongst the world's largest tea companies along w...
16 Nov 2018 | 07:00 PM
Nifty managed to end in green for the third successive week amid volatility and settled at 10,682.20...
16 Nov 2018 | 03:05 PM
Reliance Nippon Life Asset Management (RNAM) reported a net profit growth of 10.4% YoY at Rs. 111 cr...
16 Nov 2018 | 10:18 AM
• Gold prices edge higher amid Brexit turmoil • Natural gas prices plunge 18 percent in a second wil...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
8,84,202 132.61 24.46 0.49
8,84,202 132.61 22.49 0.49
8,84,202 132.61 23.58 0.49
8,84,202 132.61 25.56 0.49
2,50,161 37.52 23.35 -0.28

Shareholding Pattern

       
Promotors70.47%
Mutual Funds/UTI7.52%
FI/Banks0.53%
Insurance0.53%
FII10.92%
Government0.34%
Others1.28%

Peer Group

Company Intraday Graph
 Merck Ltd.
3,027.35(1.36)
3302
 AstraZeneca Pharma India Ltd.
1,659.15(-0.75)
3274
 Dr. Lal Pathlabs Ltd.
829.00(-3.81)
17140
 Ipca Laboratories Ltd.
755.00(0.25)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ajanta Pharma Ltd.91.90-68.7058.60
NIFTY(S&P CNX)97.45-702.85-58.90
BSE SENSEX294.68-2,206.4069.28
BSE 500138.03-1,111.09-551.75

Corporate Details

Key Personal
Madhusudan B Agrawal
Vice Chairman
Mannalal B Agrawal
Chairman
Purushottam B Agrawal
Vice Chairman
Key Address
Registered Office
Ajanta House Charkop Kandivli (West),Mumbai,Maharashtra

Tel:022-66061000, Fax:022-66061200 66061300

investorgrievance@ajantapharma.com
http://www.ajantapharma.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)